Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)

Shahid Beheshti University of Medical Sciences31 enrolled

Overview

To evaluate the effect of bevacizumab for treatment of non-AMD choroidal neovascularization (CNV); eg:angioid streaks, ocular histoplasmosis, high myopia, idiopathic,etc

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Choroidal Neovascularization

Interventions

bevacizumabDRUG

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Cases with subfoveal or juxtafoveal CNV due to a non-AMD related cause. Exclusion Criteria: * Evidence of AMD

Locations (1)

Hamid Ahmadieh, MD

Tehran, Tehran Province, Iran

Outcomes

Primary Outcomes

Visual acuity

Time frame: 6 months

Secondary Outcomes

central macular thickness

Time frame: 6 months

leakage in fluorescein angiography

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.